In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.Â
Experts from Lumanity discuss cross-functional alignment of Integrated Evidence Generation Planning (IEGP) from perspectives of strategy, clinical/regulatory, commercial and patient engagement.
As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating RWE and HEOR alongside traditional approaches when planning data generation activities to support new product registration, access, and use.
Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
Join presenters as they explore innovative approaches for:
Over the last decade as the requirements for evidence to support the various dimensions of value assessment of medicines have strengthened and the breadth of audiences has increased, Medical Affairs is realizing more potential and bringing together its capabilities for strategy, science, and communication in powerful ways. In the rapidly evolving regulatory, technological, and scientific environment, the Medical Affairs function is uniquely positioned to coordinate the identification, prioritization, strategic planning, execution and communication of the broad variety of high-quality evidence necessary to fulfill unmet needs of clinicians, payers, reimbursement agencies, policy makers, advocacy groups, and patients.
This Standard and Guidance is intended to inform learners about the Evidence Generation function, strategic direction, and operations across multiple geographies.